Literature DB >> 19671882

Natural variation within the neuronal nicotinic acetylcholine receptor cluster on human chromosome 15q24: influence on heritable autonomic traits in twin pairs.

Brinda K Rana1, Jennifer Wessel, Vafa Mahboubi, Fangwen Rao, Jeannine Haeller, Jiaur R Gayen, Eleazar Eskin, Anne M Valle, Madhusudan Das, Sushil K Mahata, Laurent Taupenot, Mats Stridsberg, Todd T Talley, Michael G Ziegler, Douglas W Smith, Nicholas J Schork, Daniel T O'Connor, Palmer Taylor.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) are combinations of subunits arranged as pentamers encircling a central cation channel. At least nine alpha and four beta subunits are expressed in the central and peripheral nervous systems; their presence in autonomic ganglia, the adrenal medulla, and central nervous system, with accompanying responses elicited by nicotinic agonists, point to their involvement in cardiovascular homeostasis. nAChRs formed by alpha3, alpha5, and beta4 subunits may regulate blood pressure (BP) by mediating release of catestatin, the endogenous nicotinic antagonist fragment of chromogranin A (CHGA) and potent inhibitor of catecholamine secretion. Genes encoding these subunits (CHRNA3, CHRNA5, and CHRNB4) are clustered on human chromosome 15q24. Because variation in this cluster may alter autonomic regulation of BP, we sequenced approximately 15 kilobase pairs in 15q24 containing their coding and 5'- and 3'-untranslated regions in 80 individuals. We identified 63 variants: 25 in coding regions of CHRNA3, CHRNA5, and CHRNB4 and 48 noncoding single-nucleotide polymorphisms (SNPs). Haplotype frequencies varied across ethnic populations. We assessed the contribution of six SNPs in the putative catestatin binding region of CHRNA3 and CHRNB4 to autonomic traits. In twins, catestatin and BP were heritable. CHRNA3 SNPs and haplotypes containing K95K (G285A) associated with circulating plasma catestatin, epinephrine levels, as well as systolic BP, suggesting altered coupling of the nAChRs to BP. Studies of chromaffin cells in vitro reveal that nicotinic agonist stimulation releases catecholamines and CHGA, a process augmented by overexpression of CHRNA3 and blocked by catestatin. These cellular events suggest a homeostatic mechanism underlying the pleiotropic actions of CHRNA3 genetic variation on autonomic function observed in twins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671882      PMCID: PMC2775266          DOI: 10.1124/jpet.109.157271

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  41 in total

1.  Nicotinic receptors in wonderland.

Authors:  T Grutter; J P Changeux
Journal:  Trends Biochem Sci       Date:  2001-08       Impact factor: 13.807

Review 2.  Emerging structure of the nicotinic acetylcholine receptors.

Authors:  Arthur Karlin
Journal:  Nat Rev Neurosci       Date:  2002-02       Impact factor: 34.870

3.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

5.  Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data.

Authors:  Na Li; Matthew Stephens
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

6.  Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT).

Authors:  Ali Roghani; Paul T Carroll
Journal:  Brain Res Mol Brain Res       Date:  2002-04-30

7.  Characterization of the genomic structure of the human neuronal nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster and identification of novel intragenic polymorphisms.

Authors:  S Duga; G Soldà; R Asselta; M T Bonati; L Dalprà; M Malcovati; M L Tenchini
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

Review 8.  Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology.

Authors:  Jon M Lindstrom
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

9.  The occurrence of chronic disease and other conditions in a large population-based cohort of native Californian twins.

Authors:  Myles Cockburn; Ann Hamilton; John Zadnick; Wendy Cozen; Thomas M Mack
Journal:  Twin Res       Date:  2002-10

Review 10.  Genetic analysis in human hypertension.

Authors:  Norihiro Kato
Journal:  Hypertens Res       Date:  2002-05       Impact factor: 3.872

View more
  6 in total

1.  Identification of CHRNA5 rare variants in African-American heavy smokers.

Authors:  Glenn A Doyle; Andrew D Chou; Wint Thu Saung; Alison T Lai; Falk W Lohoff; Wade H Berrettini
Journal:  Psychiatr Genet       Date:  2014-06       Impact factor: 2.458

2.  Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.

Authors:  Anne M Valle; Zoran Radic; Brinda K Rana; Vafa Mahboubi; Jennifer Wessel; Pei-an Betty Shih; Fangwen Rao; Daniel T O'Connor; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

3.  Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence.

Authors:  Jennifer Wessel; Sarah M McDonald; David A Hinds; Renee P Stokowski; Harold S Javitz; Michael Kennemer; Ruth Krasnow; William Dirks; Jill Hardin; Steven J Pitts; Martha Michel; Lisa Jack; Dennis G Ballinger; Jennifer B McClure; Gary E Swan; Andrew W Bergen
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

Review 4.  Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis.

Authors:  Zohara Sternberg
Journal:  Neuromolecular Med       Date:  2015-10-26       Impact factor: 3.843

5.  Associations between variation in CHRNA5-CHRNA3-CHRNB4, body mass index and blood pressure in the Northern Finland Birth Cohort 1966.

Authors:  Marika Kaakinen; Francesca Ducci; Mikko J Sillanpää; Esa Läärä; Marjo-Riitta Järvelin
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

6.  CHRNA3 rs6495308 genotype as an effect modifier of the association between daily cigarette consumption and hypertension in Chinese male smokers.

Authors:  Xiao-Ying Wu; Shan-Yu Zhou; Zhong-Zheng Niu; Tao Liu; Chuan-Bo Xie; Wei-Qing Chen
Journal:  Int J Environ Res Public Health       Date:  2015-04-14       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.